Methotrexate

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
Victoria Furer, Tali Eviatar, Devy Zisman, Hagit Peleg, Daphna Paran, David Levartovsky, Michael Zisapel, Ofir Elalouf, Ilana Kaufman, Roni Meidan, Adi Broyde, Ari Polachek, Jonathan Wollman, Ira Litinsky, Katya Meridor, Hila Nochomovitz, Adi Silberman, Dana Rosenberg, Joy Feld, Amir Haddad, Tal Gazzit, Muna Elias, Nizar Higazi, Fadi Kharouf, Gabi Shefer, Orly Sharon, Sara Pel, Sharon Nevo, Ori Elkayam

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220647; DOI: 10.1136/annrheumdis-2021-220647
Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial
Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren

Annals of the Rheumatic Diseases Aug 2021, 80 (8) 965-973; DOI: 10.1136/annrheumdis-2020-219825
Response to: ‘Correspondence on ‘Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial’’ by Jain and Dhir et al
Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220857; DOI: 10.1136/annrheumdis-2021-220857
Correspondence on ‘Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial’
Siddharth Jain, Varun Dhir

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220816; DOI: 10.1136/annrheumdis-2021-220816
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis
Serena Bugatti, Ludovico De Stefano, Silvia Balduzzi, Maria Immacolata Greco, Terenzj Luvaro, Irene Cassaniti, Laura Bogliolo, Iolanda Mazzucchelli, Bernardo D’Onofrio, Michele di Lernia, Eleonora Mauric, Daniele Lilleri, Fausto Baldanti, Antonio Manzo, Carlomaurizio Montecucco

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220862; DOI: 10.1136/annrheumdis-2021-220862
Successful BNT162b2 booster vaccinations in a patient with rheumatoid arthritis and initially negative antibody response
Fredrik N Albach, Gerd R Burmester, Robert Biesen

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220834; DOI: 10.1136/annrheumdis-2021-220834
Early reduction in circulating monocyte count predicts maintenance of remission in patients with rheumatoid arthritis treated with anti-TNF therapy
Muhammad Ruhul Amin Shipa, Raj Amarnani, Su-Ann Yeoh, M D Mainuddin, Michael R Ehrenstein

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220642; DOI: 10.1136/annrheumdis-2021-220642
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration
Ulf Lindström, Daniela Di Giuseppe, Bénédicte Delcoigne, Bente Glintborg, Burkhard Möller, Adrian Ciurea, Manuel Pombo-Suarez, Carlos Sanchez-Piedra, Kari Eklund, Heikki Relas, Bjorn Gudbjornsson, Thorvardur Jon Love, Gareth T Jones, Catalin Codreanu, Ruxandra Ionescu, Lucie Nekvindova, Jakub Závada, Nuh Atas, Servet Yolbas, Karen Minde Fagerli, Brigitte Michelsen, Žiga Rotar, Matija Tomšič, Florenzo Iannone, Maria Jose Santos, Pedro Avila-Ribeiro, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Lennart TH Jacobsson, Johan Askling, Michael J Nissen

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220097; DOI: 10.1136/annrheumdis-2021-220097
Comparison of two dose escalation strategies of methotrexate in active rheumatoid arthritis: a multicentre, parallel group, randomised controlled trial
Siddharth Jain, Varun Dhir, Amita Aggarwal, Ranjan Gupta, Bidyalaxmi Leishangthem, Shankar Naidu, Aastha Khullar, Supriya Maurya, Veena Dhawan, Shefali Khanna Sharma, Aman Sharma, Sanjay Jain

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220512; DOI: 10.1136/annrheumdis-2021-220512
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
Rebecca H Haberman, Ramin Herati, David Simon, Marie Samanovic, Rebecca B Blank, Michael Tuen, Sergei B Koralov, Raja Atreya, Koray Tascilar, Joseph R Allen, Rochelle Castillo, Amber R Cornelius, Paula Rackoff, Gary Solomon, Samrachana Adhikari, Natalie Azar, Pamela Rosenthal, Peter Izmirly, Jonathan Samuels, Brian Golden, Soumya M Reddy, Markus F Neurath, Steven B Abramson, Georg Schett, Mark J Mulligan, Jose U Scher

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220597; DOI: 10.1136/annrheumdis-2021-220597

Main menu

Methotrexate

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Methotrexate

Pages